Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Evolus (EOLS) EBT: 2018-2025

Historic EBT for Evolus (EOLS) over the last 8 years, with Sep 2025 value amounting to -$15.6 million.

  • Evolus' EBT rose 18.21% to -$15.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.8 million, marking a year-over-year decrease of 4.90%. This contributed to the annual value of -$49.8 million for FY2024, which is 19.11% up from last year.
  • As of Q3 2025, Evolus' EBT stood at -$15.6 million, which was up 8.89% from -$17.1 million recorded in Q2 2025.
  • In the past 5 years, Evolus' EBT ranged from a high of $6.4 million in Q1 2021 and a low of -$23.4 million during Q2 2022.
  • Its 3-year average for EBT is -$14.8 million, with a median of -$15.6 million in 2025.
  • Per our database at Business Quant, Evolus' EBT spiked by 132.92% in 2021 and then tumbled by 372.93% in 2022.
  • Over the past 5 years, Evolus' EBT (Quarterly) stood at -$18.2 million in 2021, then climbed by 27.86% to -$13.1 million in 2022, then rose by 10.54% to -$11.7 million in 2023, then spiked by 45.83% to -$6.4 million in 2024, then climbed by 18.21% to -$15.6 million in 2025.
  • Its last three reported values are -$15.6 million in Q3 2025, -$17.1 million for Q2 2025, and -$18.8 million during Q1 2025.